• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

essilor









anyone have thoughts on this company...opening in my area and hoping it is a great company...salary? Dont want to put way high on the desired level of salary and shoot myself in the foot and not get called cuz they think wont take less